COMMUNIQUÉS West-GlobeNewswire

-
Immunicum AB (publ) Interim Report April - June 2018
17/08/2018 -
Terveystalo Plc: Terveystalo Group Half-Year Report January 1-June 30, 2018
17/08/2018 -
Motif Bio to Present Iclaprim Data at ESCMID/ASM Conference
17/08/2018 -
Shire plc: Rule 2.9 Announcement
17/08/2018 -
HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-Encoded Technology
17/08/2018 -
Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
17/08/2018 -
Agility Health Announces Private Placement, Engages FronTier Flex Marketing and Grants Stock Options
17/08/2018 -
Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
16/08/2018 -
Immunomedics to Report Fourth Quarter and Fiscal Year 2018 Results and Host Conference Call and Webcast on August 23, 2018
16/08/2018 -
Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage
16/08/2018 -
Inspire Medical Systems, Inc. to Present at the 13th Annual Wells Fargo Securities Healthcare Conference
16/08/2018 -
Ovid Therapeutics Announces Phase 2 STARS Topline Data Accepted for Presentation at American Academy of Child And Adolescent Psychiatry Annual Meeting
16/08/2018 -
HTG Molecular Appoints Michelle R. Griffin to its Board of Directors
16/08/2018 -
Editas Medicine Announces the Completion of the Recombinant DNA Advisory Committee (RAC) Registration Process
16/08/2018 -
CORRECTION: Agritek Holdings Inc. Announces Filing Extension and Delay in Form 10-Q Report With Full Intention of Remaining Fully Reporting and Uplisted On OTCQB
16/08/2018 -
Synergy CHC Corp. Announces Expansion into Mexico
16/08/2018 -
Major shareholding announcement
16/08/2018 -
Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option
16/08/2018 -
Rafael Pharmaceuticals Receives FDA Orphan Drug Designation of CPI-613 for the Treatment of Peripheral T-Cell Lymphoma (PTCL)
16/08/2018
Pages